IRIS
PIZZORNI, CARMEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.109
Totale 14.109
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.109
Totale 14.109
Salva come PNG Salva come JPEG
Città #
Genova 10.842
Genoa 1.596
Rapallo 1.548
Vado Ligure 62
Bordighera 61
Totale 14.109
Salva come PNG Salva come JPEG
Nome #
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. 510
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 156
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 150
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 142
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 138
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 132
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 129
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 129
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 129
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 127
Timing of transition between capillaroscopic patterns in systemic sclerosis. 125
Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. 124
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 122
Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. 121
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 121
Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study 120
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 118
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 118
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 117
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 116
Vitamin D endocrine system involvement in autoimmune rheumatic diseases 114
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. 112
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients 112
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 110
Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy. 109
Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients 108
Evidence of cerebral hypoperfusion in scleroderma patients. 108
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 108
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 108
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 107
Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. 106
CTLA-4 blockade in the treatment of rheumatoid arthritis: an update 106
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon 106
null 105
Vitamin D, steroid hormones, and autoimmunity. 105
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 105
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 105
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts 104
Correlations between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients 104
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 103
Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapy. 102
Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis 101
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 101
Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study. 101
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 101
Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al. 99
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. 99
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 97
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. 96
Correlation between bone quality and microvascular damage in systemic sclerosis patients 96
Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. 96
Circadian rhythms: glucocorticoids and arthritis. 95
The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. 94
Prospective capillaroscopy-based study on transition from primary to secondary Raynaud's phenomenon: preliminary results. 93
Sex hormones and rheumatoid arthritis. 92
Anti-TNF and sex hormones 92
Apoptosis, sex hormones and adenosine deaminase levels in cultured monocytes (THP-1 cells) and synovial rheumatoid macrophages treated with methotrexate 92
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement]. 92
Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. 91
Melatonin in rheumatoid arthritis: a disease-promoting and modulating hormone? 90
Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases. 90
Advanced in naifold capillaroscopic analysis in systemic sclerosis 90
Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. 89
The apoptotic effects of testosterone on cultured synovial macrofages from rheumatoid arthrtis patients are increased by methotrexate 89
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 89
Laser speckle contrast analysis: a new method to evaluate peripheral blood perfusion in systemic sclerosis patients 89
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? 88
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. 88
Plantar pain is not always fasciitis 88
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumba 88
VITAMIN D LEVELS AND BONE LOSS IN SYSTEMIC SCLEROSIS 87
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 87
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with naifold microvascular impairment 86
Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis. 86
Intra-and inter-observer reliability of nailfold videocapillaroscopy - A possible outcome measure for systemic sclerosis-related microangiopathy. 86
Longterm Effects of Endothelin Receptor Antagonism on Microvascular Damage Evaluated by Nailfold Capillaroscopic Analysis in Systemic Sclerosis. 85
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study. 85
BONE MINERAL DENSITY AND SEASONAL VARIATIONS IN BONE TURNOVER IN SYSTEMIC SCLEROSIS PATIENTS 84
Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. 84
Androgenizing effects of cyclosporin A in rheumatoid arthritis. 84
Nailfold video-capillaroscopy in systemic sclerosis. 82
[Nailfold capillaroscopy and blood flow laser-doppler analysis of the microvascular damage in systemic sclerosis: preliminary results]. 82
The role of androgens in rheumatic diseases. 82
Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. 82
The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis 82
Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. 81
VITAMIN D STATUS AND ITS SEASONAL VARIATIONS IN PATIENTS WITH SYSTEMIC SCLEROSIS FROM NORTHWESTERN ITALY 81
Use of glucocorticoids and risk of infections. 81
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 81
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 81
Glucocorticoid management in rheumatoid arthritis: Morning or night low dose? 81
Androgens and estogens modulate the immune and inflammatory responses in rheumatoid arthritis. 80
The assessment of nailfold capillaries: comparison of dermoscopy and nailfold videocapillaroscopy 80
Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis. 79
Androgen and estrogen receptor distribution in salivary glands of Sjogren’s syndrome patients. 79
The role of nailfold videocapillaroscopy in Raynaud's phenomenon monitoring and early diagnosis of systemic sclerosis 78
VITAMIN D SERUM LEVELS CORRELATE WITH BONE MASS VALUES IN POSTMENOPAUSAL SYSTEMIC SCLEROSIS PATIENTS 78
Capillaroscopy 2016: new perspectives in systemic sclerosis. 78
Organ involvement correlates with both nailfold microangiopathy severity and fingertip blood perfusion in systemic sclerosis patients 77
Nailfold capillaroscopy-how many fingers should be examined to detect abnormality? 77
Totale 10.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.882
article - articoli 40.959
book - libri 0
conference - conferenze 1.711
curatela - curatele 0
other - altro 86
patent - brevetti 0
selected - selezionate 0
volume - volumi 126
Totale 85.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.080 0 107 152 231 365 407 558 371 488 734 504 163
2020/20211.427 76 102 376 81 93 112 51 82 137 135 100 82
2021/20222.034 54 142 160 217 55 108 172 478 118 207 95 228
2022/20231.863 200 100 23 139 335 276 18 181 302 19 245 25
2023/20241.294 48 169 16 139 82 233 93 144 45 26 71 228
2024/2025179 164 15 0 0 0 0 0 0 0 0 0 0
Totale 14.602